Infectious Diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites that can spread from one person to another or from animals to humans. Our Infectious Diseases category provides the latest news, research, and discoveries in the field of infectious diseases, including disease transmission, diagnosis, treatment, and prevention. Discover the latest insights into the most pressing infectious disease concerns of our time, such as emerging viruses, antimicrobial resistance, and vaccine development. From epidemiology and virology to microbiology and immunology, our coverage of infectious diseases provides a comprehensive look at the latest developments in this critical field. Whether you’re a medical professional or just interested in staying informed about the latest infectious disease issues, our Infectious Diseases category has everything you need to stay up-to-date and informed.
Tests show the recombinant vaccine outperforming existing vaccines in some areas. Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages…
New research highlights the fine balance between health and economic strategies in pandemic response, introducing an innovative approach that adapts to changing virus dynamics. The…
Mutation in E. coli facilitates severe disease by hindering cellulose production, revealing new approaches to fight antibiotic resistance. Queensland researchers have discovered that a mutation…
The evolution of viral tolerance in Myotis bats may help scientists prevent future pandemics, say researchers at Texas A&M. Bats carry some of the deadliest…
Researchers discovered that the sac around the lungs contains macrophages that fight flu infections by moving into the lungs, offering new insights into lung health…
Neurological symptoms are apparently not a result of SARS-CoV-2 infection of the brain. Scientists still are not sure how neurological symptoms arise in COVID-19. Is…
An international research project in which the URV has taken part has designed and manufactured a surface that has virucidal properties but does not use…
By tracking T cell activity, researchers uncover promising tuberculosis vaccine and drug targets. La Jolla Institute for Immunology (LJI) is working to guide the development…
Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis…
A new study discovered that T cells, not viruses, are responsible for neurological damage in diseases like Zika and COVID-19, suggesting new treatment strategies. For…
The JN.1 COVID-19 variant, emerging in late 2023, marks a significant shift in the virus’s evolution, emphasizing the need for sustained global health efforts. Since…
Duke-NUS-led research reveals an intranasal vaccine candidate that offers superior, long-lasting COVID-19 immunity, potentially minimizing booster requirements. Novel findings from a preclinical head-to-head comparison show…
A new study reveals the updated COVID-19 vaccine’s strong response against Omicron and other SARS-CoV-2 variants, suggesting broad protection and highlighting its significance for vulnerable…
Study shows patients hospitalized for flu or COVID-19 face increased risk of long-term health problems and death. Since the COVID-19 pandemic began, extensive research has…
A study in North Carolina has detected the bacterium responsible for scrub typhus, a serious disease, in local chiggers. The findings prompt concerns about the…
Team develops test to identify new drugs that can disable pathogens and so make real gains in public health. Antibiotic-resistant “superbugs” that can defeat efforts…
A groundbreaking study reveals that SARS-CoV-2 can linger in the lungs for months, eluding detection and potentially leading to long COVID, due to failures in…
LJI scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant. In August, researchers detected a new SARS-CoV-2…